AG2R LA Mondiale Gestion D Actifs Acquires New Stake in CME Group Inc. $CME

Key Points

• AG2R LA Mondiale Gestion D Actifs has acquired a new stake of approximately 13,394 shares in CME Group Inc., valued at $3,871,000, during the first quarter.
• Several hedge funds significantly increased their stakes in CME Group, with GQG Partners LLC increasing its stake by 7,676.3%, and other firms raising theirs by substantial percentages as well.
• CME Group recently announced a quarterly dividend of $1.25 per share, representing an annualized dividend yield of 1.9% with a payout ratio of 48.40%.

AG2R LA Mondiale Gestion D Actifs acquired a new stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 13,394 shares of the financial services provider's stock, valued at approximately $3,871,000.

A number of other hedge funds have also made changes to their positions in CME. GQG Partners LLC increased its stake in shares of CME Group by 7,676.3% during the first quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider's stock valued at $584,975,000 after acquiring an additional 2,176,685 shares during the period. Wellington Management Group LLP increased its stake in shares of CME Group by 370.5% during the first quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider's stock valued at $704,068,000 after acquiring an additional 2,089,935 shares during the period. GAMMA Investing LLC increased its stake in shares of CME Group by 32,941.0% during the first quarter. GAMMA Investing LLC now owns 1,858,887 shares of the financial services provider's stock valued at $493,144,000 after acquiring an additional 1,853,261 shares during the period. Nuveen LLC acquired a new position in shares of CME Group during the first quarter valued at approximately $218,842,000. Finally, Alliancebernstein L.P. increased its stake in shares of CME Group by 185.5% during the first quarter. Alliancebernstein L.P. now owns 1,244,608 shares of the financial services provider's stock valued at $330,182,000 after acquiring an additional 808,740 shares during the period. Institutional investors and hedge funds own 87.75% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on CME. Erste Group Bank lowered shares of CME Group from a "strong-buy" rating to a "hold" rating in a research note on Saturday, May 24th. Oppenheimer lifted their price target on shares of CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a research report on Thursday, July 24th. Wall Street Zen lowered shares of CME Group from a "hold" rating to a "sell" rating in a research report on Sunday, July 13th. Piper Sandler lifted their price target on shares of CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 15th. Finally, UBS Group decreased their price target on shares of CME Group from $305.00 to $285.00 and set a "neutral" rating on the stock in a research report on Monday. Four analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company's stock. Based on data from MarketBeat, CME Group has a consensus rating of "Hold" and an average price target of $260.60.

Insiders Place Their Bets

In other CME Group news, insider Sunil Cutinho sold 11,896 shares of CME Group stock in a transaction on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the sale, the insider owned 17,440 shares of the company's stock, valued at $4,734,436.80. This trade represents a 40.55% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director William R. Shepard bought 256 shares of the firm's stock in a transaction on Wednesday, June 25th. The shares were bought at an average cost of $270.53 per share, with a total value of $69,255.68. Following the purchase, the director directly owned 258,196 shares in the company, valued at approximately $69,849,763.88. This trade represents a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 0.30% of the company's stock.

CME Group Trading Up 1.0%

CME Group stock opened at $262.38 on Friday. The company has a 50 day moving average price of $273.85 and a 200 day moving average price of $270.21. CME Group Inc. has a 52 week low of $212.38 and a 52 week high of $290.79. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a market capitalization of $94.56 billion, a price-to-earnings ratio of 25.40, a P/E/G ratio of 4.70 and a beta of 0.43.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The firm had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same quarter last year, the business posted $2.56 EPS. The company's revenue was up 10.4% on a year-over-year basis. Research analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be paid a dividend of $1.25 per share. The ex-dividend date of this dividend is Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. CME Group's dividend payout ratio (DPR) is 48.40%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.